Detalhe da pesquisa
1.
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation.
Br J Haematol
; 203(5): 840-851, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37614192
2.
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(2): 323-332, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31618690
3.
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1079-1087, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29325829
4.
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies.
Biol Blood Marrow Transplant
; 23(10): 1685-1694, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28734876
5.
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 23(1): 67-74, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27789361
6.
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.
Biol Blood Marrow Transplant
; 23(12): 2088-2095, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28711727
7.
Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response.
Biol Blood Marrow Transplant
; 23(3): 452-458, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-28017734
8.
High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.
Blood
; 125(1): 199-205, 2015 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25377785
9.
Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer.
World J Urol
; 35(9): 1417-1423, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28204918
10.
Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(4): 705-709, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26772158
11.
Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa.
Biol Blood Marrow Transplant
; 22(8): 1449-1454, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27184623
12.
Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.
Biol Blood Marrow Transplant
; 21(11): 1981-4, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26211983
13.
Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies.
Biol Blood Marrow Transplant
; 21(12): 2160-2166, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26271191
14.
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse.
Biol Blood Marrow Transplant
; 21(12): 2106-2114, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26187863
15.
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation.
Biol Blood Marrow Transplant
; 21(5): 920-5, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25687796
16.
High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 21(11): 1985-93, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26238810
17.
Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.
Am J Kidney Dis
; 65(5): 780-4, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25600489
18.
Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.
Biol Blood Marrow Transplant
; 20(6): 787-93, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24548875
19.
Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1.
Blood
; 119(22): 5182-90, 2012 May 31.
Artigo
Inglês
| MEDLINE | ID: mdl-22510877
20.
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.
Blood
; 120(24): 4882-91, 2012 Dec 06.
Artigo
Inglês
| MEDLINE | ID: mdl-23012326